113 related articles for article (PubMed ID: 582920)
1. Different uptake of two alkylating substances by ascites tumor cells.
Schmidt H; Liss E
Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of desoxyribonucleic acid (DNA) synthesis and modification of cell multiplication of Yoshida ascites tumor cells by alkylating substances].
Liss E; Reinecke A; Palme G
Arzneimittelforschung; 1969 Jul; 19(7):1137-40. PubMed ID: 5394516
[No Abstract] [Full Text] [Related]
3. Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.
Gerhartz HH; Liss E; Schmidt H
J Cancer Res Clin Oncol; 1979 Jul; 94(3):257-63. PubMed ID: 479265
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic effect of alkylating cytostatics].
Maass H
Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
[No Abstract] [Full Text] [Related]
5. Selective inhibition of thymidine transport at low doses of the alkylating agents triethyleneiminobenzoquinone (Trenimon).
Grunicke H; Hirsch F; Wolf H; Bauer U; Kiefer G
Exp Cell Res; 1975 Feb; 90(2):357-64. PubMed ID: 1112277
[No Abstract] [Full Text] [Related]
6. [Stimulation of DPN metabolic processes in ascites tumors by low dosage roentgen irradiation and trenimon].
Rüter J; Vachek H; Oldekop M; Wüppen I; Hilz H
Biochem Z; 1966 Mar; 344(2):153-66. PubMed ID: 4293039
[No Abstract] [Full Text] [Related]
7. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
[TBL] [Abstract][Full Text] [Related]
8. Depression of histone acetylation by alkylating antitumor agents in murine cells.
Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
[TBL] [Abstract][Full Text] [Related]
9. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Draeger U; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cyclophosphamide activation.
Kondo T; Muragishi H
Gan; 1970 Apr; 61(2):145-51. PubMed ID: 5452403
[No Abstract] [Full Text] [Related]
11. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
Asbach HW
Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
[No Abstract] [Full Text] [Related]
12. Variations in carbohydrate-metabolizing activities of ascites tumor cells during growth in vivo.
Tsuiki S; Sukeno T; Saheki R; Takeda R
Sci Rep Res Inst Tohoku Univ Med; 1966 Dec; 13(3):223-8. PubMed ID: 5984022
[No Abstract] [Full Text] [Related]
13. Effect of alkylating antitumor agents on the binding of DNA to protein.
Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
[No Abstract] [Full Text] [Related]
14. Proceedings: Effect of triethyleneiminobenzoquinone (trenimon) on thymidine transport in Ehrlich ascites tumor cells.
Hirsch F; Wolf H; Grunicke H
Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1208. PubMed ID: 4477748
[No Abstract] [Full Text] [Related]
15. [Electron microscopy studies on foreign body accumulation in the nucleus and cytoplasm of ascites tumor cells].
Miyasaki K; Masutani S
Beitr Pathol Anat; 1966 Jan; 133(1):101-23. PubMed ID: 4293898
[No Abstract] [Full Text] [Related]
16. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of different phases in the cell cycle of ascites tumor cells under the influence of cyclophosphamide.
Palme G; Liss E
Antimicrob Agents Chemother (Bethesda); 1965; 5():497-502. PubMed ID: 5883465
[No Abstract] [Full Text] [Related]
18. Trenimon: biochemical, physiological and genetic effects on cells and organisms.
Obe G; Beek B
Mutat Res; 1979 Mar; 65(1):21-70. PubMed ID: 112473
[TBL] [Abstract][Full Text] [Related]
19. [Comparative quantitative studies of dye incorporation by Yoshida- and DS- carcinosarcoma-ascitic tumor cells as a contribution to the problem of natural resistance to cytostatic substances].
Kreye VA
Arzneimittelforschung; 1968 Nov; 18(11):1386-91. PubMed ID: 5755901
[No Abstract] [Full Text] [Related]
20. Increase of glycogen and oligosaccharide contents in ascites tumor cells by action of nitrogen mustard.
Tashiro T; Aoshima M; Sakurai Y
Gan; 1966 Feb; 57(1):53-61. PubMed ID: 5956662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
